Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

PowderJect and Boehringer Mannheim agreement for protein delivery

Oct. 8, 1997

Aastrom Biosciences awarded two NIH grants; begins phase I trial of UCB transplants

Oct. 8, 1997

Cell Genesys reports development of second-generation lentiviral gene delivery system

Oct. 8, 1997

NIH contemplates licensing liposomal delivery technology to Biovector Therapeutics

Oct. 7, 1997

Sequana receives Phase I SBIR grant for RAMMP technology

Oct. 7, 1997

SDD drug delivery system available for licensing from Bioglan

Oct. 6, 1997

Genetronics receives NCI grant for electroporation research

Oct. 2, 1997

Allergan and Acadia enter drug discovery collaboration

Sep. 29, 1997

Baxter and Inhale commence phase II trial using pulmonary delivery system

Sep. 26, 1997

Cel-Sci and NCI collaborate on immunotherapy research for cancer

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...